Xencor XNCR 深 滬
已收盤 07-18 16:00:00 美东时间
8.97
-0.100
-1.10%
華盛通- 最 高9.36
- 今 開9.20
- 成交量 41.74万股
- 最 低 8.95
- 昨 收 9.07
- 總市值 6.38亿
- 52周最高 27.24
- 市盈率 靜 --
- 換手率 0.59%
- 52周最低 7.16
- 委 比 -99.65%
- 總股本 7117.08万
- 歷史最高 58.345
- 量 比 0.82
- 振 幅 4.52%
- 歷史最低 5.75
- 每 手 1
- 風險率 5.81%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Avacta Appoints Dr. David Liebowitz as Chief Medical Officer to Lead Cancer Drug Strategy
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces the appointment of David Liebowitz, M.D., Ph.D. as Chief Medical Officer (CMO) and Yulii
07-01 19:04
美股大行评级 | 潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
05-10 10:00
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Polyrizon (NASDAQ:PLRZ) stock moved upwards by 57.1% to $0.58 during F...
05-10 05:06
Barclays Maintains Underweight on Xencor, Lowers Price Target to $6
Barclays analyst Peter Lawson maintains Xencor (NASDAQ:XNCR) with a Underweight and lowers the price target from $22 to $6.
05-09 00:43
Xencor Announces Executive Vice President Resignation
Xencor ( ($XNCR) ) has provided an announcement. On May 5, 2025, Xencor announc...
05-08 04:50
Xencor Q1 EPS $(0.66) Misses $(0.60) Estimate, Sales $32.73M Beat $22.41M Estimate
Xencor (NASDAQ:XNCR) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.60) by 10 percent. This is a 40.54 percent increase over losses of $(1.11) per share from the same
05-08 04:50
AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
THOUSAND OAKS, Calif., May 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the fi...
05-02 04:01
Xencor reports positive trial results for inflammatory bowel disease treatment
Xencor (NASDAQ:XNCR), on Tuesday, reported positive early results from its first study in humans of XmAb942, an antibody being developed to treat inflammatory bowel diseases like ulcerative colitis an...
04-30 04:25
美股牛股 | “AI妖股”MicroAlgo放量暴涨75%！特朗普会见零售巨头讨论关税影响
“AI妖股”重获资金关注！MicroAlgo放量暴涨75%；柯尔百货隔夜大涨超8%，特朗普会见多家零售巨头讨论关税影响>>
04-22 19:46
William Blair Initiates Coverage On Xencor with Outperform Rating
William Blair analyst Matt Phipps initiates coverage on Xencor (NASDAQ:XNCR) with a Outperform rating.
04-21 23:24
